Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
1.560
-0.200 (-11.36%)
At close: Oct 30, 2026, 4:00 PM EDT
1.580
+0.020 (1.28%)
After-hours: Oct 30, 2026, 5:07 PM EDT
Kiora Pharmaceuticals Market Cap
Kiora Pharmaceuticals has a market cap or net worth of $9.93 million as of October 30, 2026. It is the 41,488th most valuable company in the world and the 5,601st biggest in the United States. Its market cap has decreased by 16.43% in one year.
Market Cap
9.93M
Enterprise Value
-6.58M
1-Year Change
-16.43%
Global Rank
Country Rank
#5,601 United States
Category
ChartMarket Cap Chart
Since February 17, 2015, Kiora Pharmaceuticals's market cap has decreased from $35.73M to $9.93M, a decrease of -72.22%. That is a compound annual growth rate of -10.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 9.93M | 2.22% |
| Dec 31, 2025 | 9.71M | -30.96% |
| Dec 31, 2024 | 14.07M | 250.17% |
| Dec 29, 2023 | 4.02M | -34.81% |
| Dec 30, 2022 | 6.16M | -67.75% |
| Dec 31, 2021 | 19.11M | -29.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 12.21M |
| SeaStar Medical Holding | 12.15M |
| CalciMedica | 11.95M |
| Cellectar Biosciences | 11.53M |
| Tvardi Therapeutics | 11.51M |
| Passage Bio | 11.33M |
| Intensity Therapeutics | 10.90M |
| CytoMed Therapeutics | 10.75M |